FDA — authorised 2 October 2006
- Application: NDA021501
- Marketing authorisation holder: LOREAL USA
- Local brand name: CAPITAL SOLEIL 15
- Indication: CREAM — TOPICAL
- Status: approved
FDA authorised Part 1: Lotion on 2 October 2006
Yes. FDA authorised it on 2 October 2006.
LOREAL USA holds the US marketing authorisation.